Krsnaa Diagnostics

Krsnaa Diagnostics EBIT Margin

The EBIT Margin (Operating Margin) of Krsnaa Diagnostics (KRSNAA.NS) as of Oct 31, 2026 is 21.32 %. In the previous year, EBIT Margin (Operating Margin) was 14.43 % — a change of 47.75% (higher).

EBIT Margin

21.32 %

YoY

47.75%

Last updated:

EBIT Margin (Operating Margin) of Krsnaa Diagnostics is 2026 21.32 % . EBIT Margin (Operating Margin) of Krsnaa Diagnostics was 2025 14.43 % . It decreases by 47.75% higher compared to the previous year.

Krsnaa Diagnostics's operating (EBIT) margin stands at 21.3%, up from 20.0% several years earlier.

The Krsnaa Diagnostics EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
15.43 INR
Jan 1, 2020
11.77 INR
Jan 1, 2021
14.35 INR
Jan 1, 2022
19.96 INR
Jan 1, 2023
18.04 INR
Jan 1, 2024
11.49 INR
Jan 1, 2025
14.43 INR
Jan 1, 2026
21.32 INR
The Krsnaa Diagnostics EBIT Margin history
YEAREBIT MarginYoY
21.32 %+47.75%
14.43 %+25.58%
11.49 %-36.33%
18.04 %-9.59%
19.96 %+39.12%
14.35 %+21.91%
11.77 %-23.73%
15.43 %+13.02%
13.65 %+66.64%
8.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Krsnaa Diagnostics Stock analysis

What does Krsnaa Diagnostics do? Krsnaa Diagnostics Ltd provides diagnostic services across India, including radiology and pathology through X-Ray, CT scan, MRI, mammography, and tele-reporting. The company offers lab services for blood and urine investigations, supported by technology that aids healthcare professionals in diagnosing medical conditions. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS). The firm serves public and private hospitals, medical colleges, and community health centers as its primary customers. The company generates revenue through diagnostic service fees charged to hospitals, medical colleges, and community health centers. These institutions purchase the diagnostic services for their patients, utilizing Krsnaa's imaging and lab capabilities. The health packages are also sold to these institutions for patient care programs, contributing to the company's revenue streams. Krsnaa Diagnostics Ltd's product portfolio focuses on medical imaging and laboratory testing, targeting healthcare providers and institutions. The primary segments served are public and private hospitals, medical colleges, and community health centers, which rely on the company's diagnostic solutions for patient diagnostics and treatment planning. Krsnaa Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Krsnaa Diagnostics stock

EBIT Margin (Operating Margin) of Krsnaa Diagnostics is 21.32 % in 2026.

EBIT Margin (Operating Margin) of Krsnaa Diagnostics changed from 14.43 % to 21.32 %, representing a 47.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Krsnaa Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Krsnaa Diagnostics with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Krsnaa Diagnostics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Krsnaa Diagnostics